VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹18 Cr | ₹19 Cr | ₹23 Cr | ₹25 Cr | ₹15 Cr |
What is the latest Total Non-Current Liabilities ratio of VIMTA LABS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹23 Cr |
Mar2021 | ₹25 Cr |
Mar2020 | ₹15 Cr |
How is Total Non-Current Liabilities of VIMTA LABS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | -2.45 | |
Mar2023 | ₹19 Cr | -19.01 | |
Mar2022 | ₹23 Cr | -6.78 | |
Mar2021 | ₹25 Cr | 69.42 | |
Mar2020 | ₹15 Cr | - |
Compare Total Non-Current Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,180.0 Cr | 12.4% | -6% | 109.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 12.4% |
-6% |
109.5% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses